Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases

Remko de Pril, David F Fischer, Marion L C Maat-Schieman, Barbara Hobo, Rob A I de Vos, Ewout R Brunt, Elly M Hol, Raymund A C Roos, Fred W van Leeuwen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Polyglutamine diseases are characterized by neuronal intranuclear inclusions (NIIs) of expanded polyglutamine proteins, indicating the failure of protein degradation. UBB(+1), an aberrant form of ubiquitin, is a substrate and inhibitor of the proteasome, and was previously reported to accumulate in Alzheimer disease and other tauopathies. Here, we show accumulation of UBB(+1) in the NIIs and the cytoplasm of neurons in Huntington disease and spinocerebellar ataxia type-3, indicating inhibition of the proteasome by polyglutamine proteins in human brain. We found that UBB(+1) not only increased aggregate formation of expanded polyglutamines in neuronally differentiated cell lines, but also had a synergistic effect on apoptotic cell death due to expanded polyglutamine proteins. These findings implicate UBB(+1) as an aggravating factor in polyglutamine-induced neurodegeneration, and clearly identify an important role for the ubiquitin-proteasome system in polyglutamine diseases.

Original languageEnglish
Pages (from-to)1803-13
Number of pages11
JournalHuman Molecular Genetics
Volume13
Issue number16
DOIs
Publication statusPublished - 15 Aug 2004

Keywords

  • Apoptosis
  • Blotting, Western
  • Brain
  • Cell Survival
  • Cloning, Molecular
  • DNA, Complementary
  • Fluorescent Antibody Technique
  • Heredodegenerative Disorders, Nervous System
  • Humans
  • Immunohistochemistry
  • Inclusion Bodies
  • Peptides
  • Plasmids
  • Transfection
  • Tumor Cells, Cultured
  • Ubiquitin
  • Comparative Study
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases'. Together they form a unique fingerprint.

Cite this